BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Numerous Independent Groups Presented Data that Supports Apabetalone’s Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024

  Numerous GLP-1 RA and SGLT2i presentations touted their clinical results, providing continued excitement for our BETonMACE program, which observed a non-prespecified 63% reduction in MACE and heart failure hazard among patients taking next-generation glucose lowering drugs

  September 3, 2024

   · 

  6 min read
• Drug Development

  7 Hills Pharma Safely Doses First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors

  September 3, 2024

   · 

  2 min read
• Business

  Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

  September 3, 2024

   · 

  1 min read
• Press Releases

  NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024

  September 3, 2024

   · 

  5 min read
• Press Releases

  Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health

  September 3, 2024

   · 

  4 min read
• Press Releases

  Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)

  September 3, 2024

   · 

  7 min read
• Press Releases

  Vivacelle Bio Enrolls First Patient in Phase 3 Trial of Hypovolemia Due to Septic Shock for Phospholipid Nanoparticle-Based VBI-S

  September 3, 2024

   · 

  6 min read
• Press Releases

  Defence Appoints New Interim Chief Executive Officer

  September 3, 2024

   · 

  3 min read
• 

  Press Releases

  Multiplex Assay Market to Soar USD 6.75 Bn by 2034: Projections Show 4x Growth Driven by Innovations in Diagnostics and Drug Discovery

  September 3, 2024

   · 

  14 min read
• Press Releases

  Britannia Life Sciences Inc. Reports Fourth Quarter and Fiscal Year Financial Results for 2024

  September 3, 2024

   · 

  5 min read